Chinese Clinical Oncology is a peer-reviewed english-language open-access journal published by AME Publishing Company in Hong Kong, operating under an open-access model since 2012. The journal covers Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens.
Authors are required to pay an article processing charge to publish in Chinese Clinical Oncology; refer to the journal's APC page for the current rate. A waiver policy is offered for eligible authors. Articles are released under the CC BY-NC-ND license (see other journals using this license).
All submissions undergo plagiarism screening before peer review.
Keywords
oncology, cancer research, tumor
At a glance
- Publisher
- AME Publishing Company
- Country
- Hong Kong
- Primary language
- English
- License
- CC BY-NC-ND
- Peer review
- Double anonymous peer review
- OA since
- 2012
- Review time
- 23 weeks
- Plagiarism check
- Yes
ISSN
- 2304-3865
- electronic
- 2304-3873
Frequently asked questions
Is Chinese Clinical Oncology peer-reviewed?
Yes — Chinese Clinical Oncology operates a Double anonymous peer review review process.
Does Chinese Clinical Oncology charge an article processing charge (APC)?
Yes — refer to the journal's APC page for the current rate. A waiver policy is available for eligible authors.
What subjects does Chinese Clinical Oncology publish?
Chinese Clinical Oncology publishes research in Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens.
What languages does Chinese Clinical Oncology accept?
Chinese Clinical Oncology accepts manuscripts in English.
What is the ISSN of Chinese Clinical Oncology?
ISSN:
2304-3865 (print) · 2304-3873 (electronic).How do I submit a manuscript to Chinese Clinical Oncology?
Submit through the journal's official portal: visit submission page →
How long does peer review take at Chinese Clinical Oncology?
Average time from submission to publication is approximately 23 weeks.